Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/24/2014 | US8759405 Stevia extract or steviol for hair care |
06/24/2014 | US8759404 Intravenous propofol emulsion compositions having preservative efficacy |
06/24/2014 | US8759403 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions |
06/24/2014 | US8759402 Method to inhibit ischemia and reperfusion injury |
06/24/2014 | US8759401 Aqueous gel formulation and method for inducing topical anesthesia |
06/24/2014 | US8759400 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
06/24/2014 | US8759399 Halo active aromatic sulfonamide organic compounds and uses therefor |
06/24/2014 | US8759398 Phosphorus binder composition for treatment of hyperphosphatemia |
06/24/2014 | US8759397 Detergent composition |
06/24/2014 | US8759394 4-hydroxybutyric acid analogs |
06/24/2014 | US8759393 Utilization of dialkylfumarates |
06/24/2014 | US8759392 Amides as inhibitors of human secreted phospholipase A2 |
06/24/2014 | US8759391 Topical anesthetic for rapid local anesthesia |
06/24/2014 | US8759390 Chromene modulators of chemokine receptor activity |
06/24/2014 | US8759389 Thiophene-carboxamides useful as inhibitors of protein kinases |
06/24/2014 | US8759388 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
06/24/2014 | US8759387 Arylalkylamine compound and process for preparing the same |
06/24/2014 | US8759386 Pyrazole compounds as CRTH2 antagonists |
06/24/2014 | US8759385 Composition comprising azole fungicide and water soluble metal salt |
06/24/2014 | US8759384 Oxo-imidazolyl compounds |
06/24/2014 | US8759383 Inhibitors of cholesterol ester transfer protein |
06/24/2014 | US8759382 Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use |
06/24/2014 | US8759381 Two-photon absorbing water soluble fluorescent probe as a near-neutral pH indicator |
06/24/2014 | US8759380 Certain heterocycles, compositions thereof, and methods for their use |
06/24/2014 | US8759379 Inhibitors of cytochrome P450 |
06/24/2014 | US8759378 Methods for treating blood disorders |
06/24/2014 | US8759377 Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
06/24/2014 | US8759376 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
06/24/2014 | US8759375 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor |
06/24/2014 | US8759374 Certain chemical entities, compositions, and methods |
06/24/2014 | US8759373 Cyanoisoquinoline compounds and methods of use thereof |
06/24/2014 | US8759372 N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate salt |
06/24/2014 | US8759371 Heterocyclic compounds and their uses |
06/24/2014 | US8759370 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
06/24/2014 | US8759369 Inhalable solid amorphous particles comprising tiotropium bromide and a co-solid |
06/24/2014 | US8759368 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
06/24/2014 | US8759366 Aminopyrimidines as SYK inhibitors |
06/24/2014 | US8759365 Organic compounds |
06/24/2014 | US8759364 Methods of treating bone mass diseases |
06/24/2014 | US8759363 Quinazoline-based T cell proliferation inhibitors |
06/24/2014 | US8759362 Bicycloheteroaryl compounds and their use as TRPV1 ligands |
06/24/2014 | US8759361 2-phenoxy pyrimidinone analogues |
06/24/2014 | US8759360 Purine compounds |
06/24/2014 | US8759359 Substituted heteroaryl fused derivatives as PI3K inhibitors |
06/24/2014 | US8759358 Tyrosine kinase inhibitors |
06/24/2014 | US8759357 Inhibitors of fatty acid binding protein (FABP) |
06/24/2014 | US8759356 Compounds and methods for controlling fungi |
06/24/2014 | US8759355 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
06/24/2014 | US8759354 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
06/24/2014 | US8759353 Co-crystals and pharmaceutical compositions comprising the same |
06/24/2014 | US8759352 1-(4-ureidobenzoyl)piperazine derivatives |
06/24/2014 | US8759351 Methods for administering aripiprazole |
06/24/2014 | US8759350 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
06/24/2014 | US8759349 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
06/24/2014 | US8759348 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
06/24/2014 | US8759347 Inhibitors of C-FMS kinase |
06/24/2014 | US8759346 Organic compounds |
06/24/2014 | US8759345 Benzoimidazoles as prolyl hydroxylase inhibitors |
06/24/2014 | US8759344 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
06/24/2014 | US8759343 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
06/24/2014 | US8759342 Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists |
06/24/2014 | US8759340 Benzodiazepinone compounds useful in the treatment of skin conditions |
06/24/2014 | US8759339 Pyrrolo[2,1-c][1,4]naphthodiazepine linked piperazine compounds and a process for the preparation thereof |
06/24/2014 | US8759338 Heterocyclic kinase inhibitors |
06/24/2014 | US8759337 Gamma secretase modulators |
06/24/2014 | US8759336 Antiviral compounds |
06/24/2014 | US8759334 Compounds useful for the treatment of metabolic and inflammatory diseases |
06/24/2014 | US8759333 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors |
06/24/2014 | US8759331 X-ray and gamma-photon activable organic compounds, their preparation and their uses |
06/24/2014 | US8759330 Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally related pentacylic steroids |
06/24/2014 | US8759329 Testosterone gel and method of use |
06/24/2014 | US8759328 Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration |
06/24/2014 | US8759327 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism |
06/24/2014 | US8759326 Drug combinations containing PDE4 inhibitors and NSAIDs |
06/24/2014 | US8759325 Compositions and methods of treatment for inflammatory diseases |
06/24/2014 | US8759324 Method of activation of oxazaphosphorines |
06/24/2014 | US8759323 Protein phosphatase inhibitor |
06/24/2014 | US8759322 Hyaluronic acid derivative and pharmaceutical composition thereof |
06/24/2014 | US8759319 Lipid composition for improving brain function |
06/24/2014 | US8759318 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections |
06/24/2014 | US8759317 Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP) |
06/24/2014 | US8759316 Maintenance of platelet inhibition during antiplatelet therapy |
06/24/2014 | US8759315 Methods for rejuvenating |
06/24/2014 | US8759308 RNAi probes targeting cancer-related proteins |
06/24/2014 | US8759304 Compositions and methods for increasing telomerase activity |
06/24/2014 | US8759303 Compositions and methods for treating myelodysplastic syndrome |
06/24/2014 | US8759283 Methods for detecting mRNA and/or protein levels of gene in a biological sample |
06/24/2014 | US8759282 Water-soluble films comprising low-viscosity alginates |
06/24/2014 | US8759281 Antigen delivery vectors and constructs |
06/24/2014 | US8759104 Cationic lipids |
06/24/2014 | US8759097 Inhibition of dynamin related protein 1 to promote cell death |
06/24/2014 | US8759088 Lactococcus promoters and uses thereof |
06/24/2014 | US8759006 PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia |
06/24/2014 | US8758842 Process for producing 1,4-dihydroxy-2-naphthoic acid |
06/24/2014 | US8758830 Pyrrolopyridines as kinase inhibitors |
06/24/2014 | US8758826 Cannabinoid receptor binding agents, compositions, and methods |
06/24/2014 | US8758825 Sequestered antagonist formulations |
06/24/2014 | US8758824 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
06/24/2014 | US8758822 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs |
06/24/2014 | US8758820 Robust pellet |